David focuses on U.S. securities law and capital market transactions. He advises technology and pharmaceutical companies and provides counsel on all aspects of U.S. corporate and securities law, including public offerings. He provides ongoing advice to numerous Israeli companies listed on Nasdaq.

*David is a partner with the Israel law firm, Har-Even & Co., which is affiliated with Sullivan & Worcester LLP.

Representative Client Work

  • Represented an Israeli pharma company in its $69 million initial public offering and Nasdaq listing in July 2020
  • Represented an Israeli 3D printing company in a $36 million registered direct offering of American Depositary Shares in May 2020
  • Represented an Israeli 3D printing company in several public offerings of American Depositary Shares – $3.9 million (February 2020) and $13.3 million (April 2020)
  • Represented an Israeli hi-tech company in several offerings of American Depositary Shares – $13 million (February 2018), $12 million (February 2019), and a debt offering of $7 million (September 2019)
  • Represented an Israeli company engaged in automotive safety systems in several public offerings of American Depositary Shares – $2.6 million (April 2020), $5 million (May 2020), $6.4 million (June 2020)
  • Represented an Israeli cyber-security company in its $10 million initial public offering and dual listing on the Nasdaq Capital Market in August 2018, its acquisition of a private Israeli company in June 2019, and corresponding debt offering of $5 million in June 2019, and its $8.4 million public offering of American Depositary Shares and Warrants in April 2020
  • Represented an Israeli orphan drug company in its reverse merger with an Israeli pharma company in March 2019
  • Represented an Israeli company engaged in automotive safety systems in an NIS 20 million private placement of ordinary shares in June 2018, and a $6.2 million public offering of American Depositary Shares in March 2019
  • Represented an Israeli pharma company in its $12 million U.S. initial public offering, including its dual listing on Nasdaq
  • Represented an Israeli telecom company in two public offerings of ordinary shares – $28 million (October 2017) and $20 million (May 2016)
  • Represented an Israeli orphan drug company in its $35 million initial public offering and Nasdaq listing in 2014

Bar & Court Admissions

  • Israel
  • Illinois

Education

  • J.D., magna cum laude, Chicago Kent College of Law
  • B.A., magna cum laude, Bradley University 

Community Engagement

  • Israeli Bar Association

Languages

  • English
  • Hebrew

Awards & Honors

  • The Legal 500 Israel, 2020

Practices

Industries

Jump to Page